Plasma fibronectin is a prognostic biomarker of disability in Parkinson’s disease: a prospective, multicenter cohort studyShuzhen Zhu, Qing Wang, Jianmin Huang et al.|npj Parkinson s Disease|2025Cited by 18
A 5-Year Longitudinal, Multicentre Validation Study Assessing the Prognostic Value of Plasma Fibronectin in a Cohort of Parkinson's Disease ParticipantsShuzhen Zhu, Hualin Li, Zifeng Huang et al.|SSRN Electronic Journal|2023Cited by 0
Plasma Fibronectin is a Prognostic Biomarker of Disability in Parkinson's Disease: A Prospective, Multicenter Cohort StudyShuzhen Zhu, Hualin Li, Zifeng Huang et al.|SSRN Electronic Journal|2024Cited by 0